Related Experiment Video
Updated: Apr 22, 2026

Green Fluorescent Protein-based Expression Screening of Membrane Proteins in Escherichia coli
Published on: January 6, 2015
[Prokaryotic soluble expression, purification and function study of LEDGF/p75 protein]
Researchers developed a method to produce the lens epithelium-derived growth factor (LEDGF/p75) protein in E. coli. This recombinant protein is crucial for screening potential HIV-1 integrase (IN) inhibitors targeting viral replication.
Area of Science:
- Biochemistry
- Molecular Biology
- Virology
Background:
- HIV-1 integrase (IN) is essential for viral replication.
- The interaction between HIV-1 IN and LEDGF/p75 is a key target for anti-HIV drugs.
Purpose of the Study:
- To construct and express functional recombinant human lens epithelium-derived growth factor (LEDGF/p75) in E. coli.
- To establish a platform for screening inhibitors of the HIV-1 IN-LEDGF/p75 protein-protein interaction.
Main Methods:
- Synthesized and optimized the LEDGF/p75 gene for E. coli expression.
- Cloned the gene into a pGEX-4T-1 vector and transformed into E. coli BL21 (DE3).
- Purified the recombinant protein using Ni2+ affinity chromatography and analyzed via SDS-PAGE and ELISA.
Main Results:
- Successfully expressed high yields of soluble and stable recombinant LEDGF/p75 in E. coli.
- Confirmed the recombinant protein's ability to enhance HIV-1 IN strand transfer activity in vitro.
- Validated the protein's function using ELISA assays.
Conclusions:
- The developed recombinant LEDGF/p75 is suitable for functional assays.
- This work facilitates the development of a screening platform for novel anti-HIV therapeutics targeting the IN-LEDGF/p75 interaction.
More Related Videos
12:03Expression, Isolation, and Purification of Soluble and Insoluble Biotinylated Proteins for Nerve Tissue Regeneration
Published on: January 22, 2014
08:31Anaerobic Protein Purification and Kinetic Analysis via Oxygen Electrode for Studying DesB Dioxygenase Activity and Inhibition
Published on: October 3, 2018